NSAID Use Linked to Lower AMD Risk


A retrospective cohort study published in Ophthalmology suggests that NSAIDs may reduce the risk
of developing age-related macular degeneration (AMD)
. Because inflammation plays a central role in both wet (exudative) and dry (non-exudative) AMD, researchers in Taiwan investigated whether the anti-inflammatory properties of these drugs offer a protective effect.


Key Findings

The study compared 634,794 patients prescribed NSAIDs against an equal number of non-users (both groups averaging roughly 60 years old) and found:

  • Sustained Protection: NSAID users showed a reduced risk for AMD across all tracked time points, including at six months (HR: 0.31), one year (HR: 0.36), three years (HR: 0.42), and five years (HR: 0.48). Over the entire study duration, the overall hazard ratio was 0.58.

  • Drug Types: The protective effect was observed both in patients prescribed aspirin (HR: 0.72) and those taking non-selective COX inhibitors other than aspirin (HR: 0.41).

  • Subtypes & Comorbidities: Decreased risk applied to both non-exudative (HR: 0.56) and exudative (HR: 0.62) AMD. Furthermore, the risk reduction persisted even in patients with underlying health conditions like smoking, diabetes, hypertension, and rheumatoid arthritis.

Note: The study authors noted that it remains unclear if the elevated systemic inflammation associated with these comorbidities makes the patient's eyes more responsive to inflammation-modifying agents like NSAIDs.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

Keratoconus and Inflammatory Skin Conditions

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH